Stockreport

H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance [Yahoo! Finance]

AngioDynamics, Inc.  (ANGO) 
Last angiodynamics, inc. earnings: 4/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.angiodynamics.com/investor-relations
PDF Wainwright reiterated its Buy rating on AngioDynamics (NASDAQ:ANGO) with a price target of $16, following robust fiscal Q1 2026 results. H.C. Wainwright Reaffirms Buy [Read more]